Kim Burchiel, M.D., is quoted in a story highlighting OHSU’s use of newly available directional electrodes to treat patients with a widespread but under-appreciated condition known as essential tremor. One of his patients says, “It’s been a life-changer.”
Juliana Hansen, M.D., says the growing trend of labiapasty procedures could indicate a possible increase in awareness and conversation about vaginal health when “for many generations, vaginal health has been considered taboo and procedures and option for care for female genitalia weren’t available.”
American Academy of Ophthalmology
February 14, 2020
An artificial intelligence algorithm developed by OHSU and Massachusetts General Hospital to diagnose and help treat retinopathy of prematurity has been granted breakthrough status by the FDA.
International Psychogeriatric Association
February 13, 2020
In a set of recommendations to manage digital innovations in monitoring cognitive decline, Walt Dawson, Ph.D., says, “The population of people living with illnesses affecting brain health is increasing rapidly around the world. The burden of dementia will be disproportionately experienced in low- and middle-income countries.”
A news release about the upcoming South Texas Alzheimer’s Conference highlights Jeff Kaye, M.D., who will speak about technology advancing assessments and interventions for dementia.
While discussing how pharmacists can help pharmacy clients presenting with cold symptoms, Donald Backus, Pharm.D., says “We should keep track of what they’re presenting with symptom-wise and make sure it’s not something more serious.”
Todd Korthuis, M.D., is quoted in a story about a new telehealth app to improve care for substance use disorder in underserved rural areas. “It’s the wild west out there. The technology hasn’t been fully vetted yet and everyone is scrambling for market share,” he says.
Dawn Nolt, M.D. is quoted as saying OHSU would use well-established infectious disease control measures should OHSU treat a patient with the novel coronavirus.